Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide

被引：0
|
作者：
Zainab B Abdurahman
Douglas P Mack
机构：
[1] McMaster University,Dept of Clinical Immunology and Allergy
[2] McMaster University,Dept of Pediatrics
来源：
Allergy, Asthma & Clinical Immunology | / 6卷 / Suppl 2期
关键词：
Rhinitis; Allergic Rhinitis; Budesonide; Fluticasone; Fluticasone Propionate;
D O I：
10.1186/1710-1492-6-S2-P27
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] High doses of inhaled budesonide and adrenal function in children with severe asthma
    Milinarsky, A
    Fischer, S
    Giadrosich, V
    Lezana, V
    Torres, MT
    REVISTA MEDICA DE CHILE, 2006, 134 (01) : 60 - 64
  • [22] Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis
    Gilchrist, Francis J.
    Cox, Katrina J.
    Rowe, Rachel
    Horsley, Alex
    Webb, A. Kevin
    Jones, Andrew M.
    Bright-Thomas, Rowland J.
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (04) : 399 - 402
  • [23] Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
    Bleecker, ER
    Welch, MJ
    Weinstein, SF
    Kalberg, C
    Johnson, M
    Edwards, L
    Rickard, KA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) : 1123 - 1129
  • [24] Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction
    Luijk, B
    Kempsford, RD
    Wright, AM
    Zanen, P
    Lammers, JWJ
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (04) : 559 - 564
  • [25] Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma
    Foresi, A
    Mastropasqua, B
    Chetta, AF
    D'Ippolito, R
    Testi, R
    Olivieri, D
    Pelucchi, A
    CHEST, 2005, 127 (01) : 117 - 124
  • [26] Short-term treatment with a low dose of inhaled fluticasone propionate decreases the number of CD1a+ dendritic cells in asthmatic airways
    Bocchino, V
    Bertorelli, G
    Zhuo, X
    Grima, P
    Di Comite, V
    Damia, R
    Chetta, A
    Del Donno, M
    Foresi, A
    Casalini, A
    Testi, R
    Olivieri, D
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (5-6) : 253 - 259
  • [27] Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation - intersubject variability in systemic absorption from the lung
    Minto, C
    Li, B
    Tattam, B
    Brown, K
    Seale, JP
    Donnelly, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (02) : 116 - 124
  • [28] Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults
    Wilson, AM
    Brewster, HJA
    Lipworth, BJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (05) : 751 - 756
  • [29] Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma
    Fairfax, AJ
    David, V
    Douce, G
    THORAX, 1999, 54 (09) : 860 - 861
  • [30] A Dose-Response Study to Examine the Methodology for Demonstrating the Local Therapeutic Equivalence of the Fluticasone Propionate Component of an Orally Inhaled Combination Therapy of Fluticasone Propionate/Salmeterol Dry Powder
    Allan, Richard
    Haughie, Scott
    Kerwin, Edward
    Ward, Jon
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (06) : 364 - 373
12345